| Secondary |
| Hypertension |
18.7% |
| Unevaluable Event |
17.3% |
| Drug Use For Unknown Indication |
16.0% |
| Product Used For Unknown Indication |
14.0% |
| Depression |
6.0% |
| Essential Hypertension |
2.7% |
| Herpes Zoster |
2.7% |
| Hiv Infection |
2.7% |
| Rheumatoid Arthritis |
2.7% |
| Diabetes Mellitus Non-insulin-dependent |
2.0% |
| Hypercholesterolaemia |
2.0% |
| Immunosuppression |
2.0% |
| Type 2 Diabetes Mellitus |
2.0% |
| Arrhythmia |
1.3% |
| Cardiac Disorder |
1.3% |
| Cardiac Failure |
1.3% |
| Cardiac Failure Congestive |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Diabetes Mellitus |
1.3% |
| Drug Abuse |
1.3% |
|
| Hyponatraemia |
11.9% |
| Fall |
9.5% |
| Tongue Oedema |
9.5% |
| Hypertensive Crisis |
7.1% |
| Renal Failure Acute |
7.1% |
| Vomiting |
7.1% |
| Angioedema |
4.8% |
| Fluid Retention |
4.8% |
| Nephrolithiasis |
4.8% |
| Palatal Oedema |
4.8% |
| Syncope |
4.8% |
| Tongue Disorder |
4.8% |
| Accidental Drug Intake By Child |
2.4% |
| Convulsion |
2.4% |
| Drug Abuse |
2.4% |
| Drug Hypersensitivity |
2.4% |
| Eczema |
2.4% |
| Heart Sounds Abnormal |
2.4% |
| Hyperglycaemia |
2.4% |
| Hypokalaemia |
2.4% |
|
| Concomitant |
| Hypertension |
21.5% |
| Drug Use For Unknown Indication |
15.4% |
| Product Used For Unknown Indication |
15.1% |
| Type 2 Diabetes Mellitus |
5.3% |
| Depression |
4.6% |
| Prophylaxis |
4.3% |
| Diabetes Mellitus |
4.0% |
| Premedication |
4.0% |
| Rheumatoid Arthritis |
3.4% |
| Pain |
3.3% |
| Insomnia |
3.1% |
| Osteoporosis |
2.0% |
| Anxiety |
1.9% |
| Atrial Fibrillation |
1.9% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Dyslipidaemia |
1.9% |
| Abdominal Pain Upper |
1.7% |
| Arterial Occlusive Disease |
1.7% |
| Hepatic Neoplasm Malignant |
1.7% |
| Relapsing-remitting Multiple Sclerosis |
1.6% |
|
| Pancreatitis Acute |
10.2% |
| Vomiting |
10.2% |
| Renal Failure Acute |
7.1% |
| Urinary Tract Infection |
7.1% |
| Toe Amputation |
6.1% |
| Weight Decreased |
6.1% |
| Pancreatitis |
5.1% |
| Pancytopenia |
5.1% |
| Anaphylactoid Reaction |
4.1% |
| Cytolytic Hepatitis |
4.1% |
| Eosinophilia |
4.1% |
| General Physical Health Deterioration |
4.1% |
| Hypertension |
4.1% |
| Tendon Rupture |
4.1% |
| Ischaemic Stroke |
3.1% |
| Malaise |
3.1% |
| Melaena |
3.1% |
| Osteoarthritis |
3.1% |
| Quadriparesis |
3.1% |
| Somnolence |
3.1% |
|
| Interacting |
| Hypertension |
56.0% |
| Drug Use For Unknown Indication |
16.0% |
| Infarction |
8.0% |
| Adrenal Insufficiency |
4.0% |
| Anxiety |
4.0% |
| Benign Prostatic Hyperplasia |
4.0% |
| Depression |
4.0% |
| Insomnia |
4.0% |
|
| Inappropriate Antidiuretic Hormone Secretion |
50.0% |
| Hyponatraemia |
25.0% |
| Hypotension |
25.0% |
|
